Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PASSIoN trial of intranasal allogeneic mesenchymal stem cells for neonatal perinatal arterial ischemic stroke
2014-001912-20Phase 2Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Sep 2015
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of mesenchymal stem cells in perinatal arterial ischemic stroke (PAIS) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Change in lesion size, Brain growth and 1 more. Started Sep 2015; status: completed.
02
Drugs
mesenchymal stem cells
03
Conditions
perinatal arterial ischemic stroke (PAIS)
Beyond the preview
Go deeper on 2014-001912-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001912-20.